T-cell characteristics are dynamic and influenced by multiple factors. To test whether cells and the environment in the central nervous system (CNS) can influence T-cells, we tested if culturing mouse CD4
Introduction
Recently there has been a rapidly increasing recognition that extensive interactions occur between the immune and nervous systems [1, 2] . This progress is revising previous dogmas about the insular actions of these two systems, revealing instead that there are often bidirectional immune-neural interactions. An important one of these is the actions of T cells in the central nervous system (CNS), which is now known to include both beneficial and detrimental influences of T cells on CNS functions [3, 4, 5] . Beneficial CNS actions of T cells have been particularly wellestablished for their roles in contributing to cognition [6, 7, 8, 9, 10] and hippocampal neurogenesis in adult mammals [5, 7, 11] . Also well-established are the detrimental actions of T cells in certain CNS diseases, such as being major drivers of the onset and progression of multiple sclerosis [12, 13] .
Multiple sclerosis is the most common inflammatory demyelinating disease of the CNS and is widely considered an autoimmune disease caused by autoreactive T cells [13, 14] . Several of the clinical, immunological, and neuropathological features of MS are modeled in experimental autoimmune encephalomyelitis (EAE), which is induced in susceptible mice by eliciting an immune response to injected myelin antigens [15, 16] . The two major populations of effector T helper (Th) cells present in the CNS of mice that are thought to contribute to EAE are interferon-c (IFNc)-producing Th1 cells and interleukin-17A (IL-17A)-producing Th17 cells. The differentiation of naive CD4 + T cells into subtypes results from the activation of their T cell receptor (TCR) and co-stimulatory molecules in the presence of specific cytokines produced by the innate immune system [17] . IFNc and IL-12 induce the differentiation of CD4 + T cells to Th1 cells [18, 19] , whereas TGFb induces anti-inflammatory regulatory T (Treg) cell production [20] . Recent discoveries that T cell subtype characteristics can be dynamic [21, 22] have added a layer of complexity and indicates that environmental influences are capable of modulating the subtype characteristics of T cells.
Although it is evident that T cells in the CNS have a variety of actions, little is known about how the environment within the CNS affects T cells. Astrocytes are situated close to blood vessels, thus being an early cellular contact of infiltrating CD4 + T cells [23, 24] . Using in vitro co-cultures of cells, previous studies have reported that microglia and astrocytes, as well as neurons, can influence the priming or activation of T cells [25, 26, 27, 28, 29, 30] . However it is not clear if astrocytes can affect T cell differentiation characteristics, even though astrocytes are capable of producing key regulatory cytokines [23] . In the present study, the co-culture approach was applied to test if mouse primary astrocytes are capable of influencing the differentiation of co-cultured CD4 + T cells to Th1 cells or Tregs.
Materials and Methods

Ethics Statement
All mice were housed and treated in accordance with National Institutes of Health guidelines and procedures with mice were approved by the University of Miami Institutional Animal Care and Use Committee .
Mice
C57BL/6 (6-8 weeks) mice were purchased from the Jackson Laboratories. Mice were housed in a light and temperature controlled room and treated in accordance with NIH and University of Miami Institutional Animal Care and Use Committee regulations.
Astrocyte culture
Primary glia were prepared from cerebral cortices of 1 day old C57Bl/6 mice as described [31, 32] , and cultured in DMEM//F12 medium supplemented with 10% fetal bovine serum (FBS), 0.3% glucose, 2 mM L-glutamine, 10 U/mL penicillin and 10 mg/mL streptomycin. For separation of astrocytes and microglia, after 10 days of culture the cells were shaken (30 h; 250 rpm) and released microglia were discarded, to obtain .99% pure astrocytes as determined by immunostaining with the astrocyte marker glial fibrillary acidic protein (GFAP) (Millipore, Bedford, MA), ,1% were microglia. Protein-free E. coli (K235) LPS was prepared as described [33] . Cells were left untreated or stimulated with 100 ng/mL LPS for 6 h (to induce cytokine production) in medium supplemented with 10% FBS.
CD4
+ T cell isolation and activation
Spleens and lymph nodes were collected and single-cell suspensions were prepared by mechanical disruption in RPMI 1640 medium supplemented with 10% FBS, 100 IU/mL of penicillin, 100 mg/mL of streptomycin, 16 nonessential amino acids, 1 mM sodium pyruvate, 2.5 mM b-mercaptoethanol and 2 mM L-glutamine (R-10). CD4
+ T cells were isolated by magnetic sorting with DynaLbeads mouse CD4
+ beads according to the manufacturer's instructions (Invitrogen). Methods for differentiation of T cells were adapted from previously described procedures [34] . Conventional irradiated (3,000 rads) spleen and draining lymph node feeder cells were used as APCs, except where indicated otherwise, and were cultured with purified CD4
+ T cells at a ratio of 5:1. Alternatively, the same number of CD4 + T cells was cultivated on a confluent monolayer of astrocytes. CD4
+ T cells were activated with 2.5 mg/mL anti-CD3 (clone 145-11), Th1 cells were differentiated by the addition of recombinant IL-12 (10 ng/mL; R&D Systems) and anti-IL-4 (10 mg/mL; clone 11B11), and Tregs were prepared by incubation with TGFb (5 ng/mL), anti-IL-4 (10 mg/mL; clone 11B11) and anti-IFN-c (10 mg/mL; clone XMG1.2). CD4 + T cells were cultivated with astrocytes in R10 medium. Where indicated, cells were treated with 10 ng/mL brain-derived nerve growth factor (BDNF), 100 ng/mL nerve growth factor (NGF), 10 ng/mL glial derived nerve factor (GDNF), 100 mM glutamate, or 100 mM MK-801 (Sigma).
Intracellular cytokine staining
Astrocytes and CD4+ T cells were collected by mechanical pipetting and were stimulated for 4 h with PMA (50 ng/mL; Alexis) and ionomycin (750 ng/mL; Sigma) in the presence of Brefeldin A (BFA) at the recommended concentrations (BD Pharmingen) in a 96 well plate. Standard intracellular cytokine staining was carried out as described [34] . Cells were first stained extracellularly with APC-conjugated anti-CD4 (eBioscience) and fixed and permeabilized with Cytofix/Cytoperm solution (BD Pharmingen) and then were stained intracellularly with eFluo450-conjugated anti-IFN-c, phycoerythrin-conjugated anti-IL-17A, (eBioscience). Samples were acquired on a LSRII (BD) and data were analyzed with FlowJo software (Tree Star, Inc.).
Carboxyfluorescein succinimidyl ester (CFSE) labeling
CD4
+ T cells were suspended at a density of 10 7 cells per mL in PBS. CFSE (Molecular Probe) diluted in PBS was added to an equal volume of prewarmed cell suspension at a final concentration of 5 mM and the suspension was mixed rapidly. Cells were incubated at room temperature for 7 min and the reaction was stopped with FBS. Cells were centrifuged and resuspended in culture medium.
Microscopic evaluation of the number of CD4 + T cells per astrocyte
To determine if the astrocytes and the CD4 + T cells come in close contact, the proximity of the nuclei of CD4 + T cells to the nuclei of astrocytes was evaluated by microscopy. The method was modified from [35] . Cells were co-cultured, stained with Hoechst and fixed with 3.2% PFA. A ThermoFisher Cellomics ArrayScan VTI automated fluorescent microscope was used to image the wells with a 106 objective at 102461024 resolution with 9 fields per well of a 24-well plate containing co-cultured astrocytes and CD4 + T cells. Hoechst was used to segment and identify the nuclei of all cells, and the size and intensity of each individual nucleus was identified using Cellomic's ''TARGET ACTIVATION'' algorithm. This technique is comparable to looking at forward scatter and Hoechst MFI in flow-cytometry, only the location information about astrocytes and T cells is preserved. Spotfire DecisionSite software (TIBCO) was used to analyze the data to distinguish between the two populations of cells, in the same way that populations of cells are 'gated' in flow cytometry (based on controls with only one of the cell-types present).
Statistical analysis
Statistical significance was analyzed with a Mann-Whitney test or one way ANOVA with Bonferroni post-test using Prism software. A p value of less than 0.05 was considered significant.
Results
Astrocytes are sufficient to induce differentiation of CD4
+
T cells to Th1 cells
We tested if astrocytes influence the polarization of CD4 + T cells to Th1 or Treg cells by comparing T cell populations after cultivating CD4
+ T cells for 4 days on a monolayer of mouse primary astrocytes or on conventional irradiated spleen and draining lymph node feeder cells. Culturing CD4 + T cells with astrocytes without supplements of additional cytokines was sufficient to induce polarization of 12.7% of cells to IFNcproducing CD4
+ T cells, a marker of Th1 cells ( Figure 1A ). Addition of anti-IL-4 antibody ( Figure 1B ) increased the IFNcproducing CD4
+ T cell population by 3.4-fold to 4262% of cells (quantitation in Figure 1C ), whereas culturing CD4 + T cells on conventional feeder cells with anti-IL-4 only polarized 13.264% of CD4
+ T cells to IFNc-producing cells ( Figure 1C ). IL-12 is classically used to polarize CD4 + T cells to IFNc-producing cells. Upon addition of IL-12 ( Figure 1C, D) , astrocytes promoted the differentiation of 9462% CD4 + T cells towards Th1 cells , whereas IL-12 addition to feeder cell cultures resulted in the production of only 3367% of IFNc-producing CD4 + T cells. These results demonstrate that astrocytes can be potent inducers of Th1 cell production, and that the effects of astrocytes are additive to the effect of IL-12 on promoting Th1 cell differentiation.
Culturing CD4 + T cells on astrocytes also supported polarization to Tregs. Culturing CD4 + T cells on astrocytes with added TGFb and anti-IL-4 strongly induced Treg cell (3962%) production to an extent equivalent to cells cultured on conventional feeder cells (4269%) (Figure 1E, F) .
Inflammation usually coincides with increased infiltration of T cells in the CNS in conditions such as multiple sclerosis and EAE. Therefore, we tested if activated astrocytes that produce increased amounts of cytokines influence Th differentiation differently from resting astrocytes. Astrocytes were pre-activated by overnight stimulation with lipopolysaccharide (LPS), followed by washing the cells before co-culturing with CD4 + T cells. Surprisingly, activated astrocytes inhibited Th1 differentiation in the absence of IL-12, but were without effect in the presence of IL-12 ( Figure 2A ). Activated astrocytes also inhibited Treg differentiation ( Figure 2B ).
These results indicate that resting and activated astrocytes differently modulate T cells. Without activation astrocytes promote the production of Th1 and Treg cells, whereas this is impaired upon culturing CD4 + T cells on pre-activated astrocytes.
Cross-talk between Th1 cells and astrocytes is necessary to promote full Th1 differentiation
To test the hypothesis that a factor secreted by astrocytes promoted Th1 differentiation, CD4
+ T cells were cultivated with conditioned medium from cultured astrocytes. There was no effect of the conditioned medium on Th1 cell differentiation ( Figure 3A) , since it did not induce Th1 differentiation (Figure 1 ). This suggests that it is not a factor secreted by astrocytes in the absence of CD4 + T cells that promotes Th1 cell production. Instead, we hypoth- esized that CD4 + T cells stimulate astrocytes to release a factor that promotes Th1 differentiation. To test this, serial dilutions of CD4 + T cells were cultivated with astrocytes and the proportion of the generation of IFNc-producing cells was measured. Increasing dilutions of CD4 + T cells cultivated with astrocytes led to decreased percentages of Th1 cell production ( Figure 3B ), while there was no difference for Treg differentiation ( Figure 3C ). This suggests that there is a feedback loop by which the CD4 + T cells signal to astrocytes to induce production of factors that promote Th1 cell differentiation.
Are mitogenic factors involved in Th1 cell differentiation induced in the presence of astrocytes?
CFSE staining of CD4 + T cells cultured on astrocytes showed that cells incubated in Th1 polarizing conditions had a higher rate of cell division than undifferentiated CD4 + T cells or than cells incubated on irradiated lymph node cells and splenocytes in Th1 polarizing conditions ( Figure 4A ), suggesting that astrocytes may produce a mitogenic factor that promotes CD4 + T cell proliferation and differentiation. We tested if the addition of several mitogenic factors known to be secreted by astrocytes [36, 37] modulate Th1 differentiation of CD4 + cells cultured on splenocytes, including nerve growth factor (NGF), glial derived nerve factor (GDNF) and brain-derived nerve growth factor (BDNF). However, there was no increase in the Th1 cell differentiation in the presence of these factors ( Figure 4B ).
Glutamate modulates Th1 cell production
An important function of astrocytes is the buffering of glutamate, which is critical for controlling extracellular glutamate levels and for protecting neurons from excitotoxicity [36, 37] . Since this function can be impaired in CNS diseases, resulting in increased extracellular glutamate levels, we tested if glutamate impacts Th1 cell differentiation. Addition of glutamate promoted Th1 differentiation of CD4 + T cells cultured on splenocytes in the presence of anti-IL-4 and IL-12 ( Figure 5 ). Conversely, treatment with the selective NMDA receptor antagonist MK801 reduced Th1 cell differentiation ( Figure 5A ). Moreover, addition of glutamate on CD4 + T cells was sufficient to increase TBet expression, a marker of Th1 differentiation ( Figure 5B ). This suggests that in addition to producing cytokines critical for Th1 cell differentiation, the regulation of glutamate levels by astrocytes may also be an important modulator of the production of Th1 cells, similar to a previous report that glutamate released from DCs can regulate the secretion of Th1 cytokines [38] . Figure 6C ). We next tested if blocking the CD4-mediated cellcell interaction influences the differentiation of Th1 cells on astrocytes by incubation with a neutralizing antibody for CD4. Blocking CD4 was sufficient to block the differentiation towards Th1 cultured on astrocytes ( Figure 6E) , without affecting the percent of CD4 + T cells associated per astrocyte ( Figure 6F ), suggesting that the CD4 signaling is important for Th1 differentiation of CD4 + T cells cultured on astrocytes.
Th1 cells are dependent on CD4 for their differentiation on astrocytes
Discussion
In contrast to previous dogmas that T cell subtypes and characteristics are stable, it is rapidly becoming clear that T cell characteristics are dynamic and subject to change in response to the environment and other factors [21, 22] . This raises the likelihood that T cells in the CNS are responsive to alterations in the environment created by resident cells. To begin to test if astrocytes can modify T cell characteristics, we used the straightforward paradigm of testing in vitro if astrocytes are capable of influencing the development of CD4 + T cells to different subtypes. The results show that resting astrocytes predominantly promote the development of Th1 cells, but this is diminished after activation of astrocytes.
During MS and EAE, peripheral Th1 cells accumulate in the CNS and contribute to demyelination, whereas Tregs are protective [13, 14] . Here we provide evidence that CNS resident astrocytes may also play a role in contributing to the regulation of Th1 and Treg cells. Astrocytes promoted Th1 differentiation in the absence or presence of exogenous IL-12, but this was impaired when CD4
+ T cells were cultured on astrocytes pre-activated with LPS. This raises the possibility that depending on the environment in the CNS, astrocytes can contribute to the orientation of T cell characteristics towards subsets of Th cells. Although T cells in the CNS are thought to predominantly express subtype characteristics prior to infiltration, these results suggest that astrocytes may contribute to shifts in the subtype characteristics, or influence the development of any immature infiltrated CD4 + T cells, although each of these will require in vivo investigations.
In order to determine which specific astrocytic factors contribute to their modulation of Th1 cell differentiation, we analyzed candidates known to be involved in the functions of astrocytes. Among their actions, astrocytes are involved in neurotransmitter regulation, have mitogenic functions, and are modulators of inflammation [36, 37] . Because the proliferation of Th1 cells was increased in the presence of astrocytes compared with cells cultured on irradiated splenocytes, we tested if mitogenic factors secreted by astrocytes may be involved. However, incubation with NGF, BNDF or GDNF did not modulate Th1 cell differentiation, indicating that astrocytes can regulate Th1 cells by other factors or at the MHC level. The latter is consistent with the previous proposal that the strength of the TCR-MHC interaction is critical for Th1 differentiation and proliferation.
Glutamate appears to be an important regulator of T cell function. T cells have been shown to express many of the subtypes of glutamate receptors [39, 40, 41, 42] . Exposure to glutamate has + T cells were cultivated on irradiated splenocytes in the presence of 10 mg/mL anti-IL-4 alone or with 10 ng/mL IL-12 for 4 days, with or without 100 mM MK801 or 100 mM glutamate, each of which was reloaded after 2 days of polarization. Cells were washed and restimulated with PMA/ionomycin/BFA for 4 h and analyzed by flow cytometry. Flow cytometry analyses were quantified and expressed as mean been reported to modulate several functions and the proliferation of T cells by activating glutamate receptors expressed by T cells [38, 43, 44, 45, 46, 47, 48, 49] . Furthermore, the NMDA receptor antagonist memantine was reported to promote the development of Tregs [50] . A major function of astrocytes is to take up the neurotransmitter glutamate to prevent its accumulation in the synapse where it can reach levels sufficient to cause excitotoxicity in some neurological diseases. We found that glutamate has the capacity to regulate Th1 cells, as addition of exogenous glutamate promoted the production of Th1 cells. Thus, although it has been known for several years that astrocytes can interact with T cells via MHC-TCR interactions, these findings indicate that astrocytes also may affect the characteristics of T cells in the CNS, such as Th1 cell production, but whether this is critical in the development of EAE or other diseases remains to be determined. Furthermore, CD4 activation was found to be important for the differentiation of CD4 + T cells toward Th1 cells cultured on astrocytes, confirming that the TCR pathway plays an important role, since CD4 is a co-receptor of the TCR.
Although it is evident that T cells in the CNS have a variety of actions, evidence that the environment within the CNS affects resident T cells is only recently being identified. Thus, significant advances have recently been made concerning mechanisms regulating the infiltration of T cells and their actions in the CNS, but still to be defined is the dynamicity of their characteristics and the influence of the environment in the CNS on their characteristics and actions. The recent rapid growth of identified actions of T cells in healthy and diseased CNS and of the dynamic characteristics of T cells indicates that the capacity for unanticipated CNS-immune interactions should not be underestimated, such as the capacity of CNS cells to influence T cell characteristics as reported here.
